Corticosteroid therapy in nephrotic syndrome a meta-analysis of randomised controlled trials

The most commonly reported side effects were: oral thrush , nausea , headache , and pain in the pharynx or larynx . More rarely reported side effects (occurring in <1% of patients during the clinical trial) include: tachycardia , palpitations , dry mouth , allergic reaction ( bronchospasm , dermatitis , hives ), pharyngitis , muscle spasms , tremor , dizziness , insomnia , nervousness , and hypertension . Patients experiencing an allergic reaction or increase in difficulty breathing while using this medication should immediately discontinue its use and contact their physician. [4]

Patients requiring oral corticosteroids should be weaned slowly from systemic corticosteroid use after transferring to Advair Diskus. Prednisone reduction can be accomplished by reducing the daily prednisone dose by mg on a weekly basis during therapy with Advair Diskus. Lung function (mean forced expiratory volume in 1 second [FEV 1 ] or morning peak expiratory flow [AM PEF]), beta-agonist use, and asthma symptoms should be carefully monitored during withdrawal of oral corticosteroids. In addition, patients should be observed for signs and symptoms of adrenal insufficiency, such as fatigue, lassitude, weakness, nausea and vomiting, and hypotension.

Corticosteroid therapy in nephrotic syndrome a meta-analysis of randomised controlled trials

corticosteroid therapy in nephrotic syndrome a meta-analysis of randomised controlled trials

Media:

corticosteroid therapy in nephrotic syndrome a meta-analysis of randomised controlled trialscorticosteroid therapy in nephrotic syndrome a meta-analysis of randomised controlled trialscorticosteroid therapy in nephrotic syndrome a meta-analysis of randomised controlled trialscorticosteroid therapy in nephrotic syndrome a meta-analysis of randomised controlled trialscorticosteroid therapy in nephrotic syndrome a meta-analysis of randomised controlled trials

http://buy-steroids.org